Cell & Gene Therapy

CGT processes are highly manual, often patient-specific, and involve biological materials where contamination has direct consequences for patient safety. Unlike high-volume fill-finish, each batch carries its own risk profile, making standardized, structured risk assessment essential. Innerspace addresses this by systematically modeling critical interactions and embedding contamination risk logic directly into process design, documentation, and training.

Reproducibility in CGT depends on consistent operator behavior and a shared understanding of critical process steps, not just documented procedures. Innerspace uses Frame-by-Frame® to build structured process models that capture the underlying logic of each critical interaction. This creates a reliable, reusable foundation that supports reproducible execution even as processes evolve or scale.

Manual processes in CGT leave significant room for variability and human error. Frame-by-Frame® deconstructs each critical step into discrete, observable interactions. Making contamination risks visible, assessable, and trainable before they reach the cleanroom. This allows teams to proactively address risk rather than react to deviations after they occur.

Regulatory frameworks for CGT place strong emphasis on contamination control, process understanding, and operator competence. This includes EU GMP Annex 1 as well as emerging advanced therapy guidelines. Innerspace directly addresses all three by modeling human-environment interactions with scientific objectivity and generating structured, traceable documentation. The result is audit-ready evidence grounded in actual process intelligence, not procedural intent alone.